ImmunityBio Competitors and Similar CompaniesClear all
ImmunityBio's competitors and similar companies include Viralytics, MABION, Sonnet BioTherapeutics and Forbius.
 ImmunityBio ImmunityBio (formerly known as NantKwest) is a clinical-stage immunotherapy company focused on harnessing the power of the immune system using natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. |  Viralytics Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies. |  MABION Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases. |  Sonnet BioTherapeutics Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company. |  Forbius Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. | |
Founding Date | Founding Date 2014 | Founding Date 2006 | Founding Date 2007 | Founding Date 2011 | Founding Date 2011 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Culver City, US HQ San Diego, US Woburn, US | Locations Sydney, AU HQ | Locations Konstantynów Łódzki, PL HQ | Locations Princeton, US HQ | Locations Austin, US HQ Montréal, CA |
Employees | Employees 16116% increase | Employees N/A | Employees 95 | Employees 12 | Employees 8 |
Valuation ($) | Valuation ($) 4.3 b | Valuation ($) N/A | Valuation ($) 21.7 m | Valuation ($) 2.9 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $622k (FY, 2023) | Revenue (est.) N/A | Revenue (est.) zł151.7m (FY, 2023) | Revenue (est.) $18.6k (FY, 2024) | Revenue (est.) N/A |
Net income | Net income ($583.9m) (FY, 2023) | Net income N/A | Net income zł41.3m (FY, 2023) | Net income ($7.4m) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 27m | Total funding raised N/A | Total funding raised $ 750k | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Viralytics
HQ
Sydney, AU
Viralytics is a biotechnology company focused on the development and commercialization of oncology immunotherapies.
View companyMABION
HQ
Konstantynów Łódzki, PL
Employees
95
Mabion is a biotechnology company engaged in research and development of biotechnology and biosimilar drugs to treat cancer, autoimmune, and metabolic diseases.
View companySonnet BioTherapeutics
HQ
Princeton, US
Employees
12
Sonnet BioTherapeutics (formerly known as Chanticleer Holdings) is an oncology-focused biotechnology company.
View companyForbius
HQ
Austin, US
Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases.
View company